Dr. John May, M.D

NPI: 1760520712
Total Payments
$12,896
2023 Payments
$102.91
Companies
5
Transactions
23

Payment Breakdown by Category

Other$8,450 (65.5%)
Travel$2,132 (16.5%)
Consulting$1,575 (12.2%)
Food & Beverage$739.10 (5.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,350 4 64.7%
Travel and Lodging $2,132 7 16.5%
Consulting Fee $1,575 1 12.2%
Food and Beverage $739.10 10 5.7%
Charitable Contribution $100.00 1 0.8%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $12,407 17 $0 (2022)
Indivior Inc. $351.74 3 $0 (2023)
Dental Health Products, Inc. $100.00 1 $0 (2017)
Bausch & Lomb Americas Inc. $22.77 1 $0 (2022)
Synergy Pharmaceuticals Inc $14.72 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $102.91 1 Indivior Inc. ($102.91)
2022 $1,847 4 Gilead Sciences, Inc. ($1,575)
2018 $14.72 1 Synergy Pharmaceuticals Inc ($14.72)
2017 $10,932 17 Gilead Sciences Inc ($10,832)

All Payment Transactions

23 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/27/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $102.91 General
Category: OUD
09/09/2022 Gilead Sciences, Inc. Consulting Fee Cash or cash equivalent $1,575.00 General
08/06/2022 Indivior Inc. Food and Beverage In-kind items and services $116.45 General
07/26/2022 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $132.38 General
Category: OUD
03/02/2022 Bausch & Lomb Americas Inc. VYZULTA (Drug) Food and Beverage In-kind items and services $22.77 General
Category: Ophthalmology
08/15/2018 Synergy Pharmaceuticals Inc Trulance (Drug) Food and Beverage In-kind items and services $14.72 General
Category: Gastroenterology
12/15/2017 Dental Health Products, Inc. Charitable Contribution Cash or cash equivalent $100.00 General
12/14/2017 Gilead Sciences Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $250.00 General
05/03/2017 Gilead Sciences Inc Genvoya (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,550.00 General
Category: HIV
05/01/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $304.40 General
Category: HIV
05/01/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $144.40 General
Category: HIV
05/01/2017 Gilead Sciences Inc Genvoya (Drug) Food and Beverage In-kind items and services $113.55 General
Category: HIV
04/04/2017 Gilead Sciences Inc Food and Beverage In-kind items and services $16.60 General
03/03/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $576.70 General
Category: HIV
03/03/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $493.20 General
Category: HIV
03/03/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $240.00 General
Category: HIV
03/03/2017 Gilead Sciences Inc Genvoya (Drug) Food and Beverage In-kind items and services $49.46 General
Category: HIV
03/03/2017 Gilead Sciences Inc Genvoya (Drug) Food and Beverage In-kind items and services $49.46 General
Category: HIV
02/27/2017 Gilead Sciences Inc Genvoya (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: HIV
02/15/2017 Gilead Sciences Inc Genvoya (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,550.00 General
Category: HIV
02/13/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $235.13 General
Category: HIV
02/13/2017 Gilead Sciences Inc Genvoya (Drug) Travel and Lodging In-kind items and services $138.20 General
Category: HIV
02/13/2017 Gilead Sciences Inc Genvoya (Drug) Food and Beverage In-kind items and services $120.80 General
Category: HIV

About Dr. John May, M.D

Dr. John May, M.D is a Internal Medicine healthcare provider based in Sterling, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760520712.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John May, M.D has received a total of $12,896 in payments from pharmaceutical and medical device companies, with $102.91 received in 2023. These payments were reported across 23 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,350).

Practice Information

  • Specialty Internal Medicine
  • Location Sterling, VA
  • Active Since 02/02/2007
  • Last Updated 06/10/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1760520712

Products in Payments

  • Genvoya (Drug) $10,565
  • SUBLOCADE (Drug) $235.29
  • VYZULTA (Drug) $22.77
  • Trulance (Drug) $14.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Sterling